Rectal Cancer, Version 6.2020: Featured updates to the NCCN Guidelines Guidelines

  


Authors: Benson, A. B. 3rd; Venook, A. P.; Al-Hawary, M. M.; Arain, M. A.; Chen, Y. J.; Ciombor, K. K.; Cohen, S.; Cooper, H. S.; Deming, D.; Garrido-Laguna, I.; Grem, J. L.; Gunn, A.; Hoffe, S.; Hubbard, J.; Hunt, S.; Kirilcuk, N.; Krishnamurthi, S.; Messersmith, W. A.; Meyerhardt, J.; Miller, E. D.; Mulcahy, M. F.; Nurkin, S.; Overman, M. J.; Parikh, A.; Patel, H.; Pedersen, K.; Saltz, L.; Schneider, C.; Shibata, D.; Skibber, J. M.; Sofocleous, C. T.; Stoffel, E. M.; Stotsky-Himelfarb, E.; Willett, C. G.; Johnson-Chilla, A.; Gurski, L. A.
Title: Rectal Cancer, Version 6.2020: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines. These updates include clarifying the definition of rectum and differentiating the rectum from the sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer, with a focus on new treatment options for patients with BRAF V600E- or HER2 amplification-positive disease.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 18
Issue: 7
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2020-07-01
Start Page: 806
End Page: 815
Language: English
DOI: 10.6004/jnccn.2020.0032
PUBMED: 32634771
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087689875&doi=10.6004%2fjnccn.2020.0032&partnerID=40&md5=772aa8683dbebd37ff62e50ff9101fba
Notes: Article -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz
  2. Constantinos T Sofocleous
    244 Sofocleous
Related MSK Work